IE31885B1 - Reduction of corticosteroid side effects - Google Patents
Reduction of corticosteroid side effectsInfo
- Publication number
- IE31885B1 IE31885B1 IE93/68A IE9368A IE31885B1 IE 31885 B1 IE31885 B1 IE 31885B1 IE 93/68 A IE93/68 A IE 93/68A IE 9368 A IE9368 A IE 9368A IE 31885 B1 IE31885 B1 IE 31885B1
- Authority
- IE
- Ireland
- Prior art keywords
- corticosteroid
- side effects
- compositions
- pyridyl
- cortisone
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 8
- 230000000694 effects Effects 0.000 title abstract 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 abstract 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229960004544 cortisone Drugs 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- FUFLCEKSBBHCMO-KJQYFISQSA-N 11-dehydrocorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 FUFLCEKSBBHCMO-KJQYFISQSA-N 0.000 abstract 1
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 abstract 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 abstract 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 abstract 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 abstract 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229960002478 aldosterone Drugs 0.000 abstract 1
- -1 alkyl alkylamines Chemical class 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 abstract 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 abstract 1
- 229960000258 corticotropin Drugs 0.000 abstract 1
- 229960003957 dexamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 125000005265 dialkylamine group Chemical group 0.000 abstract 1
- 239000006196 drop Substances 0.000 abstract 1
- 229940050411 fumarate Drugs 0.000 abstract 1
- 229940050410 gluconate Drugs 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 abstract 1
- 229960004618 prednisone Drugs 0.000 abstract 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 abstract 1
- 229940074404 sodium succinate Drugs 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 229940095064 tartrate Drugs 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62179167A | 1967-03-09 | 1967-03-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE31885L IE31885L (en) | 1968-09-09 |
| IE31885B1 true IE31885B1 (en) | 1973-02-07 |
Family
ID=24491653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE93/68A IE31885B1 (en) | 1967-03-09 | 1968-01-23 | Reduction of corticosteroid side effects |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3474168A (enrdf_load_stackoverflow) |
| BE (1) | BE710504A (enrdf_load_stackoverflow) |
| DE (1) | DE1667925A1 (enrdf_load_stackoverflow) |
| FR (1) | FR7356M (enrdf_load_stackoverflow) |
| GB (1) | GB1175482A (enrdf_load_stackoverflow) |
| IE (1) | IE31885B1 (enrdf_load_stackoverflow) |
| IL (1) | IL29319A (enrdf_load_stackoverflow) |
| NL (1) | NL6801136A (enrdf_load_stackoverflow) |
| SE (1) | SE347874B (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4353896A (en) * | 1981-06-08 | 1982-10-12 | Levy Michael A | Penetrating topical medicament |
| US4945089A (en) * | 1987-12-29 | 1990-07-31 | Alcon Laboratories, Inc. | Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids |
| US5358943A (en) * | 1987-12-29 | 1994-10-25 | Clark Abbot F | Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids |
| US20060074063A1 (en) * | 1995-12-29 | 2006-04-06 | Fernandez-Pol Jose A | Pharmacological agent and method of treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2794763A (en) * | 1955-01-27 | 1957-06-04 | Pfizer & Co C | Pressor amines |
| US3105010A (en) * | 1959-06-19 | 1963-09-24 | Schering Corp | Steroid-amino acid compositions for preventing negative nitrogen balance |
| US3415833A (en) * | 1964-04-16 | 1968-12-10 | Unimed Inc | Pyridyl-dicarboxylic acid cyclobutane derivatives |
| US3984304A (en) * | 1974-11-11 | 1976-10-05 | Ppg Industries, Inc. | Electrode unit |
-
1967
- 1967-03-09 US US621791A patent/US3474168A/en not_active Expired - Lifetime
-
1968
- 1968-01-15 GB GB2078/68A patent/GB1175482A/en not_active Expired
- 1968-01-15 DE DE19681667925 patent/DE1667925A1/de active Pending
- 1968-01-17 IL IL29319A patent/IL29319A/en unknown
- 1968-01-19 SE SE00763/68A patent/SE347874B/xx unknown
- 1968-01-23 IE IE93/68A patent/IE31885B1/xx unknown
- 1968-01-25 NL NL6801136A patent/NL6801136A/xx unknown
- 1968-02-08 BE BE710504D patent/BE710504A/xx unknown
- 1968-02-20 FR FR140522A patent/FR7356M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1667925A1 (de) | 1971-07-22 |
| GB1175482A (en) | 1969-12-23 |
| FR7356M (enrdf_load_stackoverflow) | 1969-10-20 |
| IE31885L (en) | 1968-09-09 |
| IL29319A (en) | 1971-11-29 |
| SE347874B (enrdf_load_stackoverflow) | 1972-08-21 |
| BE710504A (enrdf_load_stackoverflow) | 1968-06-17 |
| NL6801136A (enrdf_load_stackoverflow) | 1968-09-10 |
| US3474168A (en) | 1969-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0310541B1 (de) | Antigestagen- und antiöstrogenwirksame Verbindungen zur Geburtseinleitung und zum Schwangerschaftsabbruch sowie zur Behandlung gynäkologischer Störungen | |
| DE3119051A1 (de) | Mittel zur behandlung der augen | |
| CH661517A5 (de) | Waessrige loesungen von wasserloeslichen einschlusskomplexen und verfahren zu ihrer herstellung. | |
| WO1996003130A1 (de) | Progesteronantagonist und gestagen zur behandlung der endometriose und leiomyomata uteri | |
| Gyermek | Pregnanolone: a highly potent, naturally occurring hypnotic-anesthetic agent. | |
| DE60018707T2 (de) | Anti-androgene und verfahren zur behandlung von krankheiten | |
| IE31885B1 (en) | Reduction of corticosteroid side effects | |
| DE2643936A1 (de) | Arzneimittel mit erythropoietischer wirksamkeit | |
| Derelanko et al. | Effect of corticosteroids on indomethacin-induced intestinal ulceration in the rat | |
| DE2429101B2 (de) | Alpha-isomeres des 2-chlor-9- eckige klammer auf 3'-(n'-2-hydroxyaethylpiperazinon)-propyliden eckige klammer zu -thioxanthens und dessen ester, verfahren zu deren gewinnung bzw. herstellung und diese verbindungen enthaltende mittel | |
| ES375203A1 (es) | Un procedimiento para preparar un derivado de benzotiazepi-na. | |
| DE2705002A1 (de) | Therapeutische zubereitung | |
| Howell et al. | Effect of hypophysectomy on electrolyte excretion in dogs with ascites produced by thoracic inferior vena cava constriction | |
| WO2000024388A2 (de) | Kombinationsmittel zur behandlung entzünglicher darmerkrankungen von 5-aminosalicylsäure und einem von budenosid, 6-methylprednisolon oder prednisolon | |
| DE2348197C3 (de) | Norethisteron-O-alkyloxime, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| DE3805064A1 (de) | Pharmazeutische zubereitungen zur geburtseinleitung, fuer den schwangerschaftsabbruch und zur verwendung als kontrazeptivum | |
| GB1165160A (en) | Improvements in the use of Selective Herbicides and Compositions containing Selective Herbicides | |
| Cerecedo et al. | Storage of pyridoxine in the rat | |
| DE2164988C3 (de) | 2,2-Diphenylcyclopropancarbonsäureesterderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| Swingle et al. | Effect of Crystalline Suspensions of Adrenal Steroids Upon Life-Span of Adrenalectomized Dogs | |
| AT281277B (de) | Verfahren zur Herstellung pharmazeutischer Zubereitungen | |
| Krayer et al. | Studies on veratrum alkaloids. XIV. The antiaccelerator cardiac action of derivatives of veratramine and jervine and of synthetic steroid secondary alkamines obtained from pregnenolone and from sapogenins | |
| DE4438767C2 (de) | Pharmazeutische Kombinationspräparate umfassend eine hepatoprotective Verbindung | |
| GB794488A (en) | Therapeutic composition | |
| DE1919895C (de) | 2 Phenyl 2 morpholinomethyl indan 1.3 dion |